US EditionGVB Biopharma Expands Product Portfolio with Launch of Premium CBT Isolate - PressReach
Summary by pressreach.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
GVB Biopharma Expands Product Portfolio with Launch of Premium CBT Isolate - PressReach
Industry-leading hemp and cannabinoid solutions provider GVB Biopharma unveils high-purity Cannabicitran (CBT) Isolate, broadening its suite of rare cannabinoid offerings. PRINEVILLE, Ore., March 13, 2025 /PRNewswire/ — GVB Biopharma, a premier developer, manufacturer, and global distributor of hemp-derived cannabinoid products, is proud to announce the launch of its new CBT Isolate. This latest product addition reinforces GVB Biopharma’s commit…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
